Both in Biotechnology
Alector vs Lexeo Therapeutics
Over the past year ALEC returned +50.3% and LXEO returned −68.6%; their daily moves had a correlation of 0.35.
ALEC +50.3% LXEO −68.6%Growth of $1, one year, split-adjusted
| Metric | ALEC | LXEO |
|---|---|---|
| Price | $2.21 | $3.14 |
| Market cap | $246.8M | $257.8M |
| Today | −1.34% | +2.61% |
| 1 month | +18.8% | −13.3% |
| 6 months | −6.4% | −45.6% |
| Year to date | +41.7% | −68.4% |
| 1 year | +42.6% | −68.3% |
| Revenue growth (YoY) | −57.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −692.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 17.8× | — |
| Net cash | $162.9M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 93.4% | 70.3% |
| Short % of float | 11.1% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).